B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Balicatib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Balicatib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

cyano
4 shared targets
k
3 shared targets
odanacatib
4 shared targets
boceprevir
4 shared targets
e
4 shared targets
telaprevir
4 shared targets
pf
2 shared targets
echinatin
2 shared targets
gallinamide
2 shared targets
pepstatin
3 shared targets
Loading evidence profile...

This evidence profile for Balicatib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.